A
$ Value
$0
Shares
6,142
Price
$0
Filed
May 23
Insider
Name
Wilson Frank Anders
Title
—
CIK
0001462948
Roles
Director
Transaction Details
Transaction Date
2025-05-21
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,142
Footnotes
Shares subject to the stock option award vest and become exercisable in full on 5/21/2026. | Each restricted stock unit represents a contingent right to receive one ordinary share. | Shares subject to the restricted stock unit award vest in full on 5/21/2026.
Filing Info
Wilson Frank Anders's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-05-31 | ALKS | M | — |
| 2025-05-31 | ALKS | F | $59K |
| 2025-05-31 | ALKS | M | — |
| 2025-05-21 | ALKS | A | $0 |
| 2025-05-21 | ALKS | A | $0 |
Other Insiders at ALKS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lurker Nancy | — | — | 2026-04-11 |
|
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
|
— | $70K | 2026-04-06 |
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
|
— | $320K | 2026-04-01 |